Wiley Bros. Aintree Capital, LLC Exact Sciences Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 18,518 shares of EXAS stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,518
Previous 15,472
19.69%
Holding current value
$1.24 Million
Previous $822,000
23.24%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
670Shares Held
164MCall Options Held
2.2MPut Options Held
1.69M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.19 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.1MShares$1.08 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$809 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.33MShares$357 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...